Display options
Cite
Strosberg JR, Caplin ME, Kunz PL, et al. . Lancet Oncol. 2021;22(12):1752-1763doi: 10.1016/S1470-2045(21)00572-6.
Strosberg, J. R., Caplin, M. E., Kunz, P. L., Ruszniewski, P. B., Bodei, L., Hendifar, A., Mittra, E., Wolin, E. M., Yao, J. C., Pavel, M. E., Grande, E., Van Cutsem, E., Seregni, E., Duarte, H., Gericke, G., Bartalotta, A., Mariani, M. F., Demange, A., Mutevelic, S., Krenning, E. P. (2021). . The Lancet. Oncology, 22(12), 1752-1763. https://doi.org/10.1016/S1470-2045(21)00572-6
Strosberg, Jonathan R, et al. "." The Lancet. Oncology vol. 22,12 (2021): 1752-1763. doi: https://doi.org/10.1016/S1470-2045(21)00572-6
Strosberg JR, Caplin ME, Kunz PL, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, Wolin EM, Yao JC, Pavel ME, Grande E, Van Cutsem E, Seregni E, Duarte H, Gericke G, Bartalotta A, Mariani MF, Demange A, Mutevelic S, Krenning EP. . Lancet Oncol. 2021 Dec;22(12):1752-1763. doi: 10.1016/S1470-2045(21)00572-6. Epub 2021 Nov 15. PMID: 34793718.
Copy Download .nbib Format: NLM
Share it on

Lancet Oncol. 2021 Dec;22(12):1752-1763. doi: 10.1016/S1470-2045(21)00572-6. Epub 2021 Nov 15.

[No title available]

The Lancet. Oncology

Jonathan R Strosberg, Martyn E Caplin, Pamela L Kunz, Philippe B Ruszniewski, Lisa Bodei, Andrew Hendifar, Erik Mittra, Edward M Wolin, James C Yao, Marianne E Pavel, Enrique Grande, Eric Van Cutsem, Ettore Seregni, Hugo Duarte, Germo Gericke, Amy Bartalotta, Maurizio F Mariani, Arnaud Demange, Sakir Mutevelic, Eric P Krenning,

Affiliations

  1. Moffitt Cancer Center, Tampa, FL, USA. Electronic address: [email protected].
  2. Royal Free Hospital, London, UK.
  3. Yale School of Medicine, New Haven, CT, USA.
  4. Division of Gastroenterology and Pancreatology, Université de Paris and Beaujon Hospital, AP-HP, Clichy, France.
  5. Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  6. Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  7. Division of Diagnostic Radiology, Oregon Health and Science University, Portland, OR, USA.
  8. Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  9. Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  10. Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
  11. MD Anderson Cancer Center Madrid, Madrid, Spain.
  12. Division of Digestive Oncology, University of Leuven, University Hospital Gasthuisberg, Leuven, Belgium.
  13. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  14. Portuguese Institute of Oncology, Porto, Portugal.
  15. Novartis Pharma AG, Basel, Switzerland.
  16. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  17. Department of Nuclear Medicine, Erasmus Medical Center, Rotterdam, Netherlands.

PMID: 34793718 DOI: 10.1016/S1470-2045(21)00572-6

Abstract

FUNDING: Advanced Accelerator Applications, a Novartis company.

Copyright © 2021 Elsevier Ltd. All rights reserved.

Conflict of interest statement

Declaration of interests JRS has provided consulting or advisory services for Novartis, speakers bureau services for Ipsen, Lexicon and has received research funding from Novartis. MEC has provided co

Publication Types